Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

Merck offers a 4.2% dividend yield but faces uncertainty with KEYTRUDA's LOE. Click here to find out why MRK stock is a Hold.

Despite indications that a single dose of Merck's (NYSE:MRK) human papillomavirus vaccine Gardasil could be as effective as ...

While cohort A met the primary endpoint among other endpoints in the Phase II trial, cohort B failed to meet its primary ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...

The State of Kansas announced an $895 million capital expansion project at the Merck Animal Health manufacturing facility in ...

This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.

ZoomRx polled 50 experienced oncologists and hemato-oncologists about 20 cancer drugmakers, asking the doctors to rank the ...

Today, Benzinga 's options scanner spotted 33 uncommon options trades for Merck & Co. This isn't normal. The overall ...

Merck KGaA, the German science and technology group, trimmed its profit forecast, citing a weakening US dollar and ...

Merck Animal Health is investing $895 million in a De Soto new facility, which will bring hundreds of jobs. It’s a huge ...